Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK J. Walter Thompson is expected to land international creative duties for a new urinary incontinence drug that will be co-marketed by Boehringer Ingelheim and Eli Lilly & Co., sources said. Estimated billings are $25 million.
The client selected WPP’s JWT, whose London and New York offices pitched the business, after a review involving three other shops: Omnicom’s BBDO in Dusseldorf, Germany; Interpublic’s Foote, Cone & Belding in New York; and Havas’ Euro RSCG Life in London, said sources.
Agency
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in